MedPath

Investigation of Effects of Delayed Feedback on Non-motor Symptoms in Individuals With Parkinson's Disease

Completed
Conditions
Parkinson Disease
Registration Number
NCT06217484
Lead Sponsor
Kessler Foundation
Brief Summary

Learning deficits are frequent in individuals with Parkinson's Disease. Clear feedback is integral because through feedback individuals know whether they should stick with an action that they have been doing (if the feedback is positive), or change their course of action (if the feedback is negative). Learning though immediate feedback has been shown to be depended on the brain chemical dopamine that is disrupted in individuals with Parkinson's Disease. During learning, feedback can also be presented after a delay. The investigators propose that learning through delayed feedback will lead to greater learning in individuals with Parkinson's Disease, since learning through delayed feedback does not rely on dopamine. During the proposed paradigm, participants with Parkinson's Disease complete a multiple-choice test. After making their selection on the multiple-choice test, they either see feedback immediately or are given feedback 25 minute later after reviewing their selection on the multiple-choice test. The investigators hypothesize that participants will learn better when they are provided with delayed feedback.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Only participants with scores above 24/30 on the Montreal Cognitive Assessment will be recruited for participation to exclude dementia.
Exclusion Criteria
  • Individuals with neurological conditions other than PD such as epilepsy, multiple sclerosis, brain tumors, etc. will be excluded to control for the effects these conditions have on the brain and behavior.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Percent correct responses will be collected through the computer softwaretesting lasts 60 minutes and completed in 1 day

Response accuracy per trial

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Kessler Foundation

πŸ‡ΊπŸ‡Έ

East Hanover, New Jersey, United States

Kessler Foundation
πŸ‡ΊπŸ‡ΈEast Hanover, New Jersey, United States
Kai Sucich, MA
Contact
973-323-3693
ksucich@kesslerfoundation.org
Ekaterina Dobryakova, PhD
Contact
edobryakova@kesslerfoundation.org

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.